AZTA - Azenta, Inc.
IEX Last Trade
52.27
0.250 0.478%
Share volume: 394,478
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$52.02
0.57
0.01%
View ratios
| Fiscal Date | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2024-02-08 | 2023-05-10 | 2023-08-08 | 2024-11-27 | 2024-02-08 | 2024-05-09 | 2024-08-06 | 2024-11-27 | |
| Assets | |||||||||
| Total Assets | 3.292 B | 3.250 B | 3.069 B | 2.886 B | 2.824 B | 2.563 B | 2.323 B | 2.100 B | |
| Current Assets | 1.620 B | 1.586 B | 1.511 B | 1.419 B | 1.383 B | 1.190 B | 967.658 M | 832.807 M | |
| Inventories | 145.939 M | 150.727 M | 142.102 M | 128.198 M | 127.184 M | 122.351 M | 115.270 M | 115.256 M | |
| Other Current Assets | 47.953 M | 1.278 M | 984.000 K | 13.036 M | 0.000 | 350.000 K | 834.000 K | 0.000 | |
| Short Term Investments | 522.897 M | 513.651 M | 390.492 M | 338.873 M | 281.212 M | 468.220 M | 259.296 M | 151.162 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 608.304 M | 667.365 M | 733.369 M | 678.910 M | 702.923 M | 353.491 M | 336.543 M | 310.929 M | |
| Total Non-current Assets | 304.675 M | 266.176 M | 169.422 M | 111.338 M | 61.962 M | 143.018 M | 148.086 M | 49.454 M | |
| Property Plant Equipment | 217.271 M | 215.301 M | 210.940 M | 205.744 M | 210.628 M | 200.905 M | 196.124 M | 202.654 M | |
| Other Assets | 1.455 B | 1.449 B | 1.348 B | 1.261 B | 1.231 B | 1.173 B | 1.160 B | 1.065 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.292 B | 3.250 B | 3.069 B | 2.886 B | 2.824 B | 2.563 B | 2.323 B | 2.100 B | |
| Total liabilities | 421.027 M | 354.587 M | 345.916 M | 351.220 M | 380.650 M | 340.626 M | 332.897 M | 331.074 M | |
| Total current liabilities | 249.026 M | 212.644 M | 203.627 M | 210.928 M | 235.620 M | 202.999 M | 202.574 M | 204.839 M | |
| Accounts Payable | 55.259 M | 45.306 M | 37.990 M | 35.796 M | 40.237 M | 37.319 M | 39.115 M | 44.433 M | |
| Other liabilities | 84.141 M | 69.839 M | 74.563 M | 72.611 M | 78.796 M | 74.983 M | 72.243 M | 71.660 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 84.141 M | 69.839 M | 74.563 M | 72.611 M | 78.796 M | 74.983 M | 72.243 M | 71.660 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.871 B | 2.895 B | 2.724 B | 2.535 B | 2.444 B | 2.223 B | 1.990 B | 1.769 B | |
| Common stock | 1.490 B | 1.496 B | 1.324 B | 1.157 B | 1.046 B | 1.000 B | 758.908 M | 506.548 M | |
| Retained earnings | 1.644 B | 1.639 B | 1.638 B | 1.641 B | 1.625 B | 1.488 B | 1.482 B | 1.477 B |